We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Lots of fungi (~5M!): only few cause human infections
- Only a few cause disease in normal hosts
- The global burden of fungal infections
- Invasive infections that aren't covered in this talk
- Example: intravital imaging
- Innate immunity to fungi
- Adaptive immunity to fungi
- Differentiation of T-helper cells
- Intracellular pathogen control
- Intracellular pathogen control: IL-12/IFN-g
- Adjunct IFN-g immunotherapy and cryptococcosis
- Th2 and atopic diseases
- Type-2 responses and fungi
- Allergic bronchopulmonary aspergillosis (ABPA)
- Exacerbated type-2 responses and disseminated coccidioidomycosis
- Th17 cytokines: IL-17 and IL-22
- Mucosal pathogen control
- Candidiasis
- IL-17 signaling critical for antifungal defense (mice)
- IL-17 signaling critical for antifungal defense (human)
- IL-17–targeted biologics result in mucosal candidiasis
- Syndromes of CMC that have been attributed to IL-17 impairment
- Decreased Th17 cells in HIES patients’ blood
- APECED
- Modelling oral candidiasis in Aire–/– mice
- Aire deficiency does not impair mucosal IL-17 or IL-22 immunity
- Pathogenic TCRab+ cells drive fungal susceptibility
- Inhibition of IFN-g restores mucosal fungal control
- Ruxolitinib ameliorates multiorgan autoimmunity & oral candidiasis in APECED
- Mucosal antifungal defense
- Adaptive fungal immunity – take home
- Acknowledgements and financial disclosures
Topics Covered
- The global burden of fungal infections
- Adaptive immunity to fungi
- Type-2 responses and fungi
- Mucosal pathogen control
- Candidiasis
- IL-17 signaling
- APECED
- Aire deficiency
- Mucosal antifungal defense
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Lionakis, M. (2025, November 30). Adaptive fungal immunity [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 1, 2025, from https://doi.org/10.69645/EGAQ2807.Export Citation (RIS)
Publication History
- Published on November 30, 2025
Financial Disclosures
- There are no commercial/financial matters to disclose.
Other Talks in the Series: The Immune System - Key Concepts and Questions
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, everyone. My name
is Michail Lionakis.
I'm a physician-scientist at
the National Institute of
Allergy and Infectious Diseases
at the National Institutes of
Health in the United States.
Today, we'll talk about
adaptive fungal immunity.
0:18
Estimates indicate
that there are
up to 5 million
different fungal species
in the environment,
and yet, a very small fraction
of them cause human disease.
There are two major
reasons for that.
One, there are potent immune
responses against fungi,
part of which we will
talk about today.
Second, there is
temperature exclusion
for the vast majority
of these fungi,
which cannot grow in
temperatures above 30 degrees.
Therefore, they
cannot survive in
temperatures of mammals,
particularly humans,
that are 37°C and above.
Now, what I've listed
here in this slide is
an abbreviated version of
the major human
fungal pathogens,
and they're divided into
three different
morphological states:
yeast, filamentous molds,
and dimorphic endemic fungi.
1:10
These comprise the vast majority
of pathogens that
cause human disease.
What's an important element to
recognize very early on is that,
with the exception of two
superficial fungal infections
that are highlighted here,
vaginal yeast infections
are caused by
Candida species and
trichophyton or
dermatophytic
infections that are
superficial in the skin and
the nails that can happen in
otherwise healthy
and normal hosts.
Any infections beyond
these two superficial
fungal infections,
especially when they're
severe or refractory,
should indicate to clinicians
that an investigation is
needed for an
underlying host effect.
These are not
infections that happen
in otherwise healthy
individuals.